Open Access iconOpen Access

ARTICLE

crossmark

Investigation of the feasibility of NRAV as a biomarker for hepatocellular carcinoma

JUN LIU1,2,3,#, WENLI LI3, RUYUE LU1,2, JIAQING XU1,2, CHUNHUI JIANG4, JUNLIN DUAN3, LINGZHI ZHANG1,#,*, GUANFU WANG1, JIAXI CHEN1,2,#,*

1 Department of Clinical Laboratory, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Linhai, China
2 Key Laboratory of System Medicine and Precision Diagnosis and Treatment of Taizhou, Taizhou, China
3 Department of Clinical Laboratory, Dongguan Hospital of Traditional Chinese Medicine, Dongguan, China
4 School of Basic Medical Sciences Forensic Medicine, Hangzhou Medical College, Hangzhou, China

* Corresponding Authors: LINGZHI ZHANG. Email: email; JIAXI CHEN. Email: email
# The aforementioned authors made an equal contribution to this study

TSP_OR_43575.pdf

  • 1040

    View

  • 255

    Download

  • 0

    Like

Share Link